Internal jugular vein versus subclavian vein as the percutaneous insertion site for totally implantable venous access devices: a meta-analysis of comparative studies

Table 6 Sensitivity analyses comparing IJV versus SCV

Outcomes	OR (95 % CI)
Outcomes	Base case^a	Using fixed-effects model	RCTs included^a	Non-randomized cohort studies included^a
TIVAD-related infections	0.71 (0.48–1.04)	0.70 (0.47–1.03)	0.47 (0.17–1.28)	0.76 (0.50–1.16)
Catheter-related thrombotic complications	0.76 (0.38–1.51)	0.91 (0.57–1.43)	0.90 (0.17–4.68)	0.56 (0.27–1.16)
Total major mechanical complications	0.38 (0.24–0.61)	0.36 (0.26–0.49)	0.30 (0.17–0.53)	0.44 (0.22–0.88)
Catheter dislocation	0.43 (0.22–0.84)	0.43 (0.23–0.83)	NA^b	0.40 (0.15–1.07)
Malfunction	0.42 (0.28–0.62)	0.42 (0.28–0.62)	0.28 (0.12–0.64)	0.47 (0.30–0.74)
Catheter fracture	0.47 (0.21–1.05)	0.38 (0.18–0.78)	NA^b	0.50 (0.15–1.61)